Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C

BACKGROUND: New biomarkers are needed to identify the stage of hepatitis C virus (HCV)-infected diseases in order to reduce the mortality rates. Herein, we investigated whether serum 3β-hydroxysterol Δ24-reductase antibody (DHCR24 Ab) may serve as a prognostic marker for hepatitis C infection progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezzikouri, Sayeh, Kimura, Kiminori, Sunagozaka, Hajime, Kaneko, Shuichi, Inoue, Kazuaki, Nishimura, Tomohiro, Hishima, Tsunekazu, Kohara, Michinori, Tsukiyama-Kohara, Kyoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535309/
https://www.ncbi.nlm.nih.gov/pubmed/26288822
http://dx.doi.org/10.1016/j.ebiom.2015.04.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535309/
https://www.ncbi.nlm.nih.gov/pubmed/26288822
http://dx.doi.org/10.1016/j.ebiom.2015.04.007

Ejemplares similares